Search Results - "MacQuillan, G"

P209 INCREASED DNA METHYLATION IS OBSERVED IN HCV rs12979860 CC HCV PATIENTS WITH LOW HEPATOCELLULAR MxA PROTEIN LEVELS by Messineo, A, DeBoer, B, Platten, M, Huang, Y, Jeffrey, G, MacQuillan, G

Get full text

Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients by Nwaba, A., MacQuillan, G., Adams, L. A., Garas, G., Delriviere, L., Augustson, B., DeBoer, B., Moody, H., Jeffrey, G. P.

“…Thrombotic microangiopathy (TMA) is a potentially fatal complication in solid organ and bone marrow transplant patients, with reported incidence of 0.5–3% and…”
Get full text

The association between chronic hepatitis C infection and cardiovascular risk by Pateria, P., Jeffrey, G. P., MacQuillan, G., Speers, D., Ching, H., Chinnaratha, M. A., Watts, G. F., Adams, L. A.

“…Background Vascular disease is a common cause of death in patients with chronic hepatitis C (CHC) infection; however, the association between CHC and…”
Get full text

Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir +/− ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis –Final results of the REV1TAL study by Lubel, J.S, Pianko, S, Thompson, A, Strasser, S, Dore, G, Stuart, K, MacQuillan, G, Iser, D, Mitchell, J, Gazzola, A, Chivers, S, Mishra, G, Gow, P, George, J, Gough, J, Tse, E, Zekry, A, Levy, M, Fragomeli, V, Morales, B, Sasadeusz, J, Nazareth, S, Bollipo, S, Jones, T, Wade, A, Cheng, W, Wigg, A, Roberts, S

Get full text

Real World Evaluation of Viekira Pak (Ritonavir Boosted Paritaprevir, Ombitasvir and Dasabuvir +/− Ribavirin) in HCV Genotype 1 Targeting Advanced Liver Disease (The Revital Study) by Lubel, J.S, Pianko, S, Thompson, A, Strasser, S, Stuart, K, Gow, P, Mitchell, J, Gazzola, A, Chivers, S, Mishra, G, Nazareth, S, Jones, T, Gough, J, Bollipo, S, Wade, A, Tse, E, MacQuillan, G, George, J, Roberts, S

Get full text

P430 SELECTIVE INTERNAL RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA: COMBINATION WITH SORAFENIB IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMES by Ma, M.X, Adams, L, Garas, G, Macquillan, G, O'dea, M, Samuelson, S, Tibballs, J, Mac Nicholas, R

Get full text

LEVETIRACETAM AS A POSSIBLE CAUSE OF FULMINANT LIVER FAILURE by TAN, T. C. H, DE BOER, B. W, MITCHELL, A, DELRIVIERE, L, ADAMS, L. A, JEFFREY, G. P, MACQUILLAN, G

Get full text

Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study by Huang, Y., de Boer, W. B., Adams, L. A., MacQuillan, G., Bulsara, M. K., Jeffrey, G. P.

“…Background and Aims Rates of long‐term clinical outcomes of chronic hepatitis C in patients with none, mild or severe liver fibrosis are required to determine…”
Get full text

Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new "trimorphic" syndrome by Talbot-Smith, A, Syn, W-K, MacQuillan, G, Neil, D, Elias, E, Ryan, P

“…This is the first report of familial idiopathic pulmonary fibrosis associated with hepatic nodular regenerative hyperplasia and bone marrow hypoplasia. Four…”
Get more information

Hepatic epithelioid haemangioendothelioma: challenges in diagnosis and management by Thin, L. W. Y., Wong, D. D., De Boer, B. W., Ferguson, J. M., Adams, L., MacQuillan, G., Delriviere, L., Mitchell, A., Jeffrey, G. P.

“…Background:  Hepatic epithelioid haemangioendothelioma (HEH) is a rare, low grade malignant neoplasm of endothelial origin which is difficult to diagnose and…”
Get full text

Malignant peripheral nerve sheath tumour of the liver by Subramaniam, K., Dessauvagie, B., Hardie, M., Weber, D., Adams, L., Macquillan, G., Jeffrey, G., Garas, G., de Boer, B.

Get full text

Comparison of noninvasive models of fibrosis in chronic hepatitis B by Raftopoulos, S. C., George, J., Bourliere, M., Rossi, E., de Boer, W. B., Jeffrey, G. P., Bulsara, M., Speers, D. J., MacQuillan, G., Ching, H. L. I., Kontorinis, N., Cheng, W., Flexman, J., Fermoyle, S., Rigby, P., Walsh, L., McLeod, D., Adams, L. A.

“…Background and goals Liver fibrosis influences treatment and surveillance strategies in chronic hepatitis B (CHB). This multicenter study aimed to examine the…”
Get full text

Unsuspected colchicine overdose in a female patient presenting as an acute abdomen by BLACKHAM, R. E, LITTLE, M, BAKER, S, AUGUSTSON, B. M, MACQUILLAN, G. C

“…We report a case of multi-system organ failure as a result of unsuspected colchicine overdose in a patient with known gout and bulimia nervosa. The patient had…”
Get full text

Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: a depressing experience by MacQuillan, G.C., Mutimer, D.

“…Background: Between 1988 and 2002, eight patients were referred to our unit from other institutions, for management of fulminant hepatic failure (FHF)…”
Get full text

Malignant fibrous histiocytoma complicating nephrogenic systemic fibrosis post liver transplantation by So, K., MacQuillan, G. C., Adams, L. A., Delriviere, L., Mitchell, A., Moody, H., Wood, D. J., Junckerstorff, R. C., Jeffrey, G. P.

“…A 46‐year‐old man with cirrhosis secondary to hepatitis C virus infection and alcohol underwent orthotopic liver transplantation, which required urgent…”
Get full text

Outcome, tolerability and compliance of compassionate use interferon and ribavirin for hepatitis C infection in a shared care hospital clinic by Kontorinis, N., Garas, G., Young, J., Speers, D., Chester, B. P., MacQuillan, G. C., De Boer, B., Chapman, M. D., Forster, E., Jeffrey, G. P.

“…Background and aims:  To determine response rate, side‐effects and compliance in patients with chronic hepatitis C virus (HCV) infection following treatment…”
Get full text

546 VERY LOW ENDOGENOUS LEVELS OF HEPATOCELLULAR MXA PROTEIN SUGGESTS MINIMAL ACTIVATION OF THE TYPE I INTERFERON PATHWAY IN CHRONIC HBV DISEASE by Wallace, M, Messineo, A, Duffy, S, Adams, L, Jeffrey, G, Speers, D, de Boer, B, Platten, M, Cheng, W, MacQuillan, G

Get full text

Delayed myelopathic presentation of the acquired hepatocerebral degeneration syndrome by LEWIS, M. B, MACQUILLAN, G, BAMFORD, J. M, HOWDLE, P. D

Get full text

Urgent liver transplantation for acute liver failure due to parvovirus B19 infection complicated by primary Epstein-Barr virus and cytomegalovirus infections and aplastic anaemia by So, K., Macquillan, G., Garas, G., Delriviere, L., Mitchell, A., Speers, D., Mews, C., Augustson, B., De Boer, W. B., Baker, D., Jeffrey, G. P.

“…An 11‐year‐old boy presented with hepatic failure secondary to parvovirus B19 infection, requiring urgent liver transplantation. His recovery was complicated…”
Get full text

Immunological markers predicting outcome in patients with hepatitis C treated with interferon-α and ribavirin by Lee, Silvia, MacQuillan, Gerry C, Keane, Niamh M, Flexman, James, Jeffrey, Gary P, French, Martyn AH, Brochier, Jean, Price, Patricia

“…Type 1 (T1) cytokine responses are required for the clearance of hepatitis C virus by cytotoxic T lymphocytes, but can promote liver damage. Interferon‐α…”
Get full text